|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cooper JS, Zhang Q, Pajak TF, Forastiere
AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Long-term follow-up of the RTOG 9501/intergroup phase III
trial: Postoperative concurrent radiation therapy and chemotherapy
in high-risk squamous cell carcinoma of the head and neck. Int J
Radiat Oncol Biol Phys. 84:1198–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adelstein DJ, Saxton JP, Rybicki LA,
Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR and Carroll
MA: Multiagent concurrent chemoradiotherapy for locoregionally
advanced squamous cell head and neck cancer: Mature results from a
single institution. J Clin Oncol. 24:1064–1071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fung C and Grandis JR: Emerging drugs to
treat squamous cell carcinomas of the head and neck. Expert Opin
Emerg Drugs. 15:355–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YJ, Chang JT, Liao CT, Wang HM, Yen
TC, Chiu CC, Lu YC, Li HF and Cheng AJ: Head and neck cancer in the
betel quid chewing area: Recent advances in molecular
carcinogenesis. Cancer Sci. 99:1507–1514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Terazono K, Yamamoto H, Takasawa S, Shiga
K, Yonemura Y, Tochino Y and Okamoto H: A novel gene activated in
regenerating islets. J Biol Chem. 263:2111–2114. 1988.PubMed/NCBI
|
|
8
|
Takasawa S: Regenerating gene (REG)
product and its potential clinical usage. Expert Opin Ther Targets.
20:541–550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao J, Wang J, Wang H and Lai M: Reg
proteins and their roles in inflammation and cancer of the human
digestive system. Adv Clin Chem. 61:153–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moriizumi S, Watanabe T, Unno M,
Nakagawara K, Suzuki Y, Miyashita H, Yonekura H and Okamoto H:
Isolation, structural determination and expression of a novel reg
gene, human regI beta. Biochim Biophys Acta. 1217:199–202. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lasserre C, Simon MT, Ishikawa H, Diriong
S, Nguyen VC, Christa L, Vernier P and Brechot C: Structural
organization and chromosomal localization of a human gene (HIP/PAP)
encoding a C-type lectin overexpressed in primary liver cancer. Eur
J Biochem. 224:29–38. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nata K, Liu Y, Xu L, Ikeda T, Akiyama T,
Noguchi N, Kawaguchi S, Yamauchi A, Takahashi I, Shervani NJ, et
al: Molecular cloning, expression and chromosomal localization of a
novel human REG family gene. REG III Gene. 340:161–170.
2004.PubMed/NCBI
|
|
13
|
Hartupee JC, Zhang H, Bonaldo MF, Soares
MB and Dieckgraefe BK: Isolation and characterization of a cDNA
encoding a novel member of the human regenerating protein family:
Reg IV. Biochim Biophys Acta. 1518:287–293. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watanabe T, Yonemura Y, Yonekura H, Suzuki
Y, Miyashita H, Sugiyama K, Moriizumi S, Unno M, Tanaka O, Kondo H,
et al: Pancreatic beta-cell replication and amelioration of
surgical diabetes by Reg protein. Proc Natl Acad Sci USA.
91:3589–3592. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asahara M, Mushiake S, Shimada S, Fukui H,
Kinoshita Y, Kawanami C, Watanabe T, Tanaka S, Ichikawa A, Uchiyama
Y, et al: Reg gene expression is increased in rat gastric
enterochromaffin-like cells following water immersion stress.
Gastroenterology. 111:45–55. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Macadam RC, Sarela AI, Farmery SM,
Robinson PA, Markham AF and Guillou PJ: Death from early colorectal
cancer is predicted by the presence of transcripts of the REG gene
family. Br J Cancer. 83:188–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harada K, Zen Y, Kanemori Y, Chen TC, Chen
MF, Yeh TS, Jan YY, Masuda S, Nimura Y, Takasawa S, et al: Human
REG I gene is up-regulated in intrahepatic cholangiocarcinoma and
its precursor lesions. Hepatology. 33:1036–1042. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Violette S, Festor E, Pandrea-Vasile I,
Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M
and Lesuffleur T: REG IV, a new member of the regenerating gene
family, is overexpressed in colorectal carcinomas. Int J Cancer.
103:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yonemura Y, Sakurai S, Yamamoto H, Endou
Y, Kawamura T, Bandou E, Elnemr A, Sugiyama K, Sasaki T, Akiyama T,
et al: REG gene expression is associated with the infiltrating
growth of gastric carcinoma. Cancer. 98:1394–1400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dhar DK, Udagawa J, Ishihara S, Otani H,
Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M
and Nagasue N: Expression of regenerating gene I in gastric
adenocarcinomas: Correlation with tumor differentiation status and
patient survival. Cancer. 100:1130–1136. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bishnupuri KS, Luo Q, Murmu N, Houchen CW,
Anant S and Dieckgraefe BK: REG IV activates the epidermal growth
factor receptor/Akt/AP-1 signaling pathway in colon
adenocarcinomas. Gastroenterology. 130:137–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayashi K, Motoyama S, Koyota S, Koizumi
Y, Wang J, Takasawa S, Itaya-Hironaka A, Sakuramoto-Tsuchida S,
Maruyama K, Saito H, et al: REG I enhances chemo- and
radiosensitivity in squamous cell esophageal cancer cells. Cancer
Sci. 99:2491–2495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayashi T, Matsubara A, Ohara S, Mita K,
Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N and
Yasui W: Immunohistochemical analysis of REG IV in urogenital
organs: Frequent expression of REG IV in prostate cancer and
potential utility as serum tumor marker. Oncol Rep. 21:95–100.
2009.PubMed/NCBI
|
|
24
|
Zhou L, Zhang R, Wang L, Shen S, Okamoto
H, Sugawara A, Xia L, Wang X, Noguchi N, Yoshikawa T, et al:
Upregulation of REG I alpha accelerates tumor progression in
pancreatic cancer with diabetes. Int J Cancer. 127:1795–1803. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kimura M, Naito H, Tojo T, Itaya-Hironaka
A, Dohi Y, Yoshimura M, Nakagawara K, Takasawa S and Taniguchi S:
REG Iα gene expression is linked with the poor prognosis of lung
adenocarcinoma and squamous cell carcinoma patients via discrete
mechanisms. Oncol Rep. 30:2625–2631. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masui T, Ota I, Itaya-Hironaka A, Takeda
M, Kasai T, Yamauchi A, Sakuramoto-Tsuchida S, Mikami S, Yane K,
Takasawa S and Hosoi H: Expression of REG III and prognosis in head
and neck cancer. Oncol Rep. 30:573–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mikami S, Ota I, Masui T, Itaya-Hironaka
A, Shobatake R, Okamoto H, Takasawa S and Kitahara T: Effect of
resveratrol on cancer progression through the REG III expression
pathway in head and neck cancer cells. Int J Oncol. 49:1553–1560.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ota H, Tamaki S, Itaya-Hironaka A,
Yamauchi A, Sakuramoto-Tsuchida S, Morioka T, Takasawa S and Kimura
H: Attenuation of glucose-induced insulin secretion by intermittent
hypoxia via down-regulation of CD38. Life Sci. 90:206–211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakagawa K, Takasawa S, Nata K, Yamauchi
A, Itaya-Hironaka A, Ota H, Yoshimoto K, Sakuramoto-Tsuchida S,
Miyaoka T, Takeda M, et al: Prevention of REG I-induced β-cell
apoptosis by IL-6/dexamethasone through activation of HGF gene
regulation. Biochim Biophys Acta. 1833:2988–2995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamauchi A, Itaya-Hironaka A,
Sakuramoto-Tsuchida S, Takeda M, Yoshimoto K, Miyaoka T, Fujimura
T, Tsujinaka H, Tsuchida C, Ota H and Takasawa S: Synergistic
activations of REG Iα and REG Iβ promoters by IL-6 and
glucocorticoids through JAK/STAT pathway in human pancreatic β
cells. J Diabetes Res. 2015:1730582015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujimura T, Fujimoto T, Itaya-Hironaka A,
Miyaoka T, Yoshimoto K, Yamauchi A, Sakuramoto-Tsuchida S, Kondo S,
Takeda M, Tsujinaka H, et al: Interleukin-6/STAT pathway is
responsible for the induction of gene expression of REG Iα, a new
auto-antigen in Sjögren's syndrome patients, in salivary duct
epithelial cells. Biochem Biophys Rep. 2:69–74. 2015.PubMed/NCBI
|
|
32
|
Tsujinaka H, Itaya-Hironaka A, Yamauchi A,
Sakuramoto-Tsuchida S, Ota H, Takeda M, Fujimura T, Takasawa S and
Ogata N: Human retinal pigment epithelial cell proliferation by the
combined stimulation of hydroquinone and advanced glycation
end-products via up-regulation of VEGF gene. Biochem Biophys Rep.
2:123–131. 2015.PubMed/NCBI
|
|
33
|
Takasawa S, Kuroki M, Nata K, Noguchi N,
Ikeda T, Yamauchi A, Ota H, Itaya-Hironaka A, Sakuramoto-Tsuchida
S, Takahashi I, et al: A novel ryanodine receptor expressed in
pancreatic islets by alternative splicing from type 2 ryanodine
receptor gene. Biochem Biophys Res Commun. 397:140–145. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Renaud S and de Lorgeril M: Wine, alcohol,
platelets, and the French paradox for coronary heart disease.
Lancet. 20:1523–1526. 1992. View Article : Google Scholar
|
|
35
|
Frémont L: Biological effects of
resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cal C, Garban H, Jazirehi A, Yeh C,
Mizutani Y and Bonavida B: Resveratrol and cancer: Chemoprevention,
apoptosis, and chemo-immunosensitizing activities. Curr Med Chem
Anticancer Agents. 3:77–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kundu JK and Surh YJ: Cancer
chemopreventive and therapeutic potential of resveratrol:
Mechanistic perspectives. Cancer Lett. 269:243–261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG and Pezzuto JM: Cancer chemopreventive activity of resveratrol,
a natural product derived from grapes. Science. 10:218–220. 1997.
View Article : Google Scholar
|
|
39
|
Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB,
Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell
cycle arrest of human T24 bladder cancer cells in vitro and
inhibits tumor growth in vivo. Cancer Sci. 101:488–493. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang S, Li W, Sun H, Wu B, Ji F, Sun T,
Chang H, Shen P, Wang Y and Zhou D: Resveratrol elicits
anti-colorectal cancer effect by activating miR-34c-KITLG in vitro
and in vivo. BMC Cancer. 15:9692015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tan L, Wang W, He G, Kuick RD, Gossner G,
Kueck AS, Wahl H, Opipari AW and Liu JR: Resveratrol inhibits
ovarian tumor growth in an in vivo mouse model. Cancer.
122:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan Y, Wei X, Zhang W, Wang X, Wang K, Du
B and Xiao J: Resveratrol enhances the radiosensitivity of
nasopharyngeal carcinoma cells by downregulating E2F1. Oncol Rep.
37:1833–1841. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE
and Zhang H: In vitro and in vivo evaluation of the antitumor
efficiency of resveratrol against lung cancer. Asian Pac J Cancer
Prev. 14:1703–1706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Estrov Z, Shishodia S, Faderl S, Harris D,
Van Q, Kantarjian HM, Talpaz M and Aggarwal BB: Resveratrol blocks
interleukin-1beta-induced activation of the nuclear transcription
factor NF-kappaB, inhibits proliferation, causes S-phase arrest,
and induces apoptosis of acute myeloid leukemia cells. Blood.
102:987–995. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liang YC, Tsai SH, Chen L, Lin-Shiau SY
and Lin JK: Resveratrol-induced G2 arrest through the inhibition of
CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem
Pharmacol. 65:1053–1060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
ElAttar TM and Virji AS: Modulating effect
of resveratrol and quercetin on oral cancer cell growth and
proliferation. Anticancer Drugs. 10:187–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yeh CB, Hsieh MJ, Lin CW, Chiou HL, Lin
PY, Chen TY and Yang SF: The antimetastatic effects of resveratrol
on hepatocellular carcinoma through the downregulation of a
metastasis-associated protease by SP-1 modulation. PLoS One.
8:e566612013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shankar S, Singh G and Srivastava RK:
Chemoprevention by resveratrol: Molecular mechanisms and
therapeutic potential. Front Biosci. 12:4839–4854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia
J, Liu J, Chen N, Li M and Zhu R: Resveratrol inhibits
proliferation in human colorectal carcinoma cells by inducing G1/S
phase cell cycle arrest and apoptosis through caspase/cyclin CDK
pathways. Mol Med Rep. 10:1697–1702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang G, Guo X, Chen H, Lin T, Xu Y, Chen
Q, Liu J, Zeng J, Zhang XK and Yao X: A resveratrol analog,
phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2
liver cancer cells. Bioorg Med Chem Lett. 22:2114–2118. 2012.
View Article : Google Scholar : PubMed/NCBI
|
